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1. Introduction
In the early 1870s, John Hughlings Jackson, the father of modern epileptology wrote, that a
seizure is “a symptom, and implies only that there is an occasional, an excessive, and a
disorderly discharge of nerve tissue” [1]. When one considers that he wrote this more than 50
years before the first human electroencephalographic recordings [2], his level of insight is quite
remarkable. Indeed, his later definition of epilepsy as “the name for occasional, sudden,
excessive, rapid, and local discharge of grey matter” [3] could be used without alteration today.
There is a key difference between Jackson’s two definitions: his later definition no longer
included the concept of seizures as “disorderly”. While seizures are a symptom of a disorder,
the temporal pattern of signs and symptoms of seizures are far from disorderly or disorgan‐
ized; this was evident to Jackson in the march of seizure activity through somatosensory cortex
[1,4]. Today, relying not only on seizure semiology, but also electroencephalographic, neuro‐
imaging, and animal models, we can without hesitation state that seizure activity does not
spread randomly through the brain, but moves through anatomically constrained pathways
and networks.
These pathways are the focus of this chapter; we will discuss specific brain networks that are
capable of seizure generation, seizure propagation, and seizure suppression. From the
perspective of preclinical research, we will emphasize several points:
1. How do we identify seizure circuits?
2. What is the importance of animal models for understanding seizures (with an emphasis
on circuit-level manipulations and species-specific features)?
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
3. How do emerging technologies enable translation of network-level manipulations to the
clinic?
2. Identifying seizure circuits
Seizure semiology can provide insight into the brain networks impacted for a given seizure
type: for example, the “fencing posture” seen in patients with frontal lobe seizures involving
pre-motor cortex can be recapitulated by selective stimulation of pre-motor cortex [5,6].
Similarly, sensory-specific auras e.g., odors in temporal lobe epilepsy can be localized to
piriform cortex, [7,8], complex visual hallucinations in anteromedial temporal lobe, occipito‐
temporal and occipital epilepsy [9]. These symptoms provide an index of regions impacted by
seizures, and the temporal order of the occurrence of these symptoms can provide a measure
of seizure spread. However, working backwards from these symptoms to identify the path
and origin of seizure propagation is a near impossible challenge.
Take, for example, electrical wiring in a house as an anology: a surge of power may cause the
lights to flicker in the living room, but that does not necessitate (or even indicate) that the surge
started in the living room. Indeed, we know that both parallel and serial wires exist in the
house, connecting power sources to fuse boxes to distribution nodes. Various signs and
symptoms (burnt wiring, a tripped circuit breaker, etc.) may represent primary causes or
secondary effects. Troubleshooting a circuit problem in the house, as complex as it may be, is
feasible because there are wiring diagrams to guide you. Without these wiring diagrams
tracing a problem would be much more complicated.
At the present, we are working, at best, with very incomplete wiring diagrams for the brain.
Thus, we assert that understanding how seizure networks are wired in the “normal” brain is
essential to determine how faults in this wiring leads to chronic seizures.
A variety of “mapping” approaches have been employed to identify brain regions engaged by
seizures, including electrographic, metabolic (e.g., 2-deoxyglucose), immediate early gene
(e.g., fos, zif), and functional magnetic resonance imaging [10–19]. While informative, these
approaches, in isolation, only identify areas activated by seizures. Mapping approaches alone
cannot determine the role of a region in initiation, propagation, or seizure suppression; these
determinations can only be made on the basis of circuit manipulations. The need for circuit-
level manipulations is one of several reasons that animal models are vital for deciphering
seizure circuitry.
3. Importance of preclinical research using animal models
Studies in human patients have provided many valuable insights into the networks supporting
seizures, but the conclusions that can be drawn from these studies are limited by the following:
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1. Changes observed in association with repeated or recurrent seizures cannot be readily
identified as cause, effect, or compensation.
2. The great deal of variability across patients and studies with respect to diagnosis, etiology,
and treatment.
3. The inability to use matched controls for invasive procedures.
Animal models overcome these limitations. For example, it is only by directly manipulating a
brain pathway or region that one can determine whether the structure is necessary for seizure
initiation, amplification, distribution, or inhibitory (feedback) control. These direct manipu‐
lations include circumscribed lesions, electrical stimulation, pharmacological inactivation/
silencing, and optogenetic approaches.
When these techniques are applied to intact, normal animals, their impact on the circuitry can
be evaluated uncompromised by preexisting pathologies. Moreover, the effect of the manip‐
ulation can be studied in both animals with a seizure profile and in control animals that are
seizure naïve, allowing one to determine how pathology changes circuit function.
Four major types of animal models have been used in epilepsy research: genetic (naturally-
occurring and engineered), evoked epileptogenesis, and evoked seizures. Entire texts have
been written on this subject (see for example, [20]), so our discussion below is by no means
intended to be comprehensive.
Naturally-occurring and inbred models are seen in a variety of species, ranging from mouse
(e.g., the El mouse [21–24]; and others [25]), rats (e.g., GEPR rats [26–28]; Wistar Audiogenic
Rats [29,30]), gerbils [31], dogs [32], and non-human primates (e.g., baboons [33]). The truly
spontaneous seizures that occur in these cases suggest that the circuitry that produces epilepsy
has been highly conserved over phylogeny.
Transgenic models of epilepsy are of increasing importance as new mutations for inherited
epilepsies are discovered. These models have been used to identify abnormalities at the
microcircuit level (e.g., interneurons in the SCN1A knockout mice [34]), but abnormalities at
the macrocircuit level still require investigation for most of these models.
Models that evoke epileptogenesis are vital when the goal is to identify what neuroplas‐
tic changes, if any, lead to epilepsy. However, if the goal is to delineate networks through
which seizures preferentially propagate, then the use of an acute or subacute seizure model
is  most  appropriate,  especially  a  model  that  does  not  cause  brain  injury.  It  may  be
worthwhile to compare the pattern of seizure propagation in an injured vs uninjured brain,
but for this purpose, the injury should be highly controlled and reproducible. Unfortunate‐
ly, models such as status-epilepticus (SE) induced spontaneous seizures suffer from some
of  the  one  of  the  same  drawbacks  associated  with  studies  in  patient  populations,  e.g.,
heterogeneity of injury. Moreover, SE can cause severe and widespread damage that often
exceeds the level of damage seen clinically [35]. The need for highly reproducible and focal
epileptogenic  insults  may  potentially  be  filled  by  controlled  models  of  traumatic  brain
injury, which provide greater control over the location and extent of damage [36-38].
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4. Types of models and manifestations: what is seizure-related and what is
due to compensatory mechanisms?
Determining how seizure networks are changed by epileptogenesis is a necessary step in
understanding epilepsy, however, this can only be understood in the context of a comparison
between the “normal” and “disease” state. The need to examine seizure propagation in a
“normal” network is one of several reasons that evoked seizure models are a powerful tool in
modern preclinical epileptology. In addition to this utility, evoked seizure models may be
preferable for examining network mechanisms because they offer experimental control of
seizure timing, severity, etc. This contrasts with most models of epileptogenesis, in which
seizures occur spontaneously and unpredictably.
5. Seizure models evoked by pharmacological agents
In rats and mice, systemic administration of GABA-A receptor antagonists (bicuculline,
pentylenetetrazole, picrotoxin, beta-carbolines) trigger, in a dose-dependent manner, myo‐
clonic, clonic (complex partial/limbic-motor), and tonic-clonic seizures (for a review see: [39]).
These compounds have been used to screen virtually every anticonvulsant drug currently
available for clinical use. At least one of these compounds (pentylenetetrazole, Metrazol) has
been used to trigger tonic-clonic seizures in human patients. In the non-human primate, most
of these compounds trigger generalized tonic-clonic response at the lowest effective dose; this
may reflect higher sensitivity of hindbrain seizure networks as compared to limbic forebrain
networks in the monkey (discussed below).
Other chemoconvulsants (e.g., pilocarpine, kainate) have been widely used for modeling
epileptogenesis, and have also been used to examine seizure circuitry [40,41]. Non-convulsant
seizure triggering agents (e.g., gammabutyrolactone) have been used to evaluate circuitry
underlying thalamocortical spike-and-wave seizures [42].
Focal application of drugs or electrical stimulation of discrete brain nuclei allows for highly
controlled and reproducibly evoked seizures of focal or partial onset. This approach also allows
for multiple sites within a network to be manipulated. An example of an especially sensitive
and circumscribed site in the forebrain effective for triggering complex partial seizures is “Area
Tempestas”. This functionally defined region is located in the anterior deep piriform cortex
and has been identified in rodents and non-human primates [43–48]. Interestingly, fMRI and
PET data suggest that an anatomically homologous area exists in human patients with epilepsy
[49]. Moreover, unruptured aneurysms of the middle cerebral artery, located in close proximity
to piriform cortex, have been associated with unilateral olfactory auras and complex partial
seizures (e.g., [7,8]).
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6. Multiple seizure networks
While a seizure can appear to “progress” on a continuum from complex partial to generalized
tonic-clonic, the progression actually results from successive engagement of independent and
dissociable seizure networks: one network supporting complex partial seizures and another
supporting tonic-clonic seizures [50–52].
For example, complex partial seizures can be evoked by stimulation of the piriform cortex [43],
while activation of the inferior colliculus [53] and/or reticular nuclei [54] triggers tonic-clonic
seizures. While it is striking that such focal manipulations can trigger these seizures, the
independence of these seizure networks is even more impressive. In both the cat and rat,
disconnection of the forebrain from the hindbrain via precollicular transections does not
impede the ability of the forebrain to show characteristic EEG seizure responses to focal or
systemic chemoconvulsant treatment [50,52,55]. Thus, communication with the hindbrain is
not necessary for forebrain seizures. Moreover, these animals are still capable of demonstrating
normal tonic-clonic and running/bouncing clonus. Thus, communication with the forebrain is
not necessary for hindbrain seizures. These data provide a compelling argument for the
independence of these seizure networks, an observation that has been supported by localiza‐
tion of focal trigger zones and circuits for these various seizure types. This leads us to the
question, are these seizure “trigger zones” necessarily the same as a “seizure focus”?
7. Insights into seizure foci from animal models
It is often assumed that the first site to show ictal activity is the site of seizure initiation. By
focally evoking seizures from piriform cortex in the rat, we have found that this is not
necessarily the case. Shortly after bicuculline microinjection, piriform cortex displays an inter-
ictal like pattern, while ictal activity can be seen in other limbic brain regions. Thus the first
ictal activity can appear in a site distal to the site that triggers a seizure.
Clinically, sites of histopathology are often examined as presumptive seizure foci. While in
some cases the site(s) of pathology may indeed be the site(s) of seizure onset, animal models
have demonstrated that this is not true in all cases. For example, in the tish rat (a model of
cortical heterotopia), the normotopic neurons, not the heterotopic neurons, are more likely to
display epileptiform activity [56]. Moreover, suppression of activity within the heterotopias
reduces epileptiform activity only within the heterotopia and not within normotopic cortex;
conversely, suppression of activity within normotopic cortex suppresses epileptiform activity
in both normotopic and heterotopic cortex.
Indeed, even in a highly controlled animal model (e.g., electrically-induced self-sustained
status epilepticus), the site within the limbic network showing earliest ictal electrographic
activity can vary both between and within subjects [57]. Together, these findings suggest that
pathology is not by necessity a clear indicator of the site of seizure initiation. While this does
not preclude the possibility that a seizure can begin at the site of pathology, it underscores that
this is not necessarily the case.
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8. Translating semiology and terminology across species
Much of the terminology that is used to describe seizures in animal models has been borrowed
from the clinic. However, because seizure semiology differs across species, accurate mapping
of terms presents a challenge.
For example, there are behavioral differences in seizures evoked from area tempestas in the
monkey as compared to rodents. In the monkey, these seizures are characterized by facial
automatisms and arm posturing – behaviors that are strikingly similar to those seen during
complex partial seizures in humans. These seizures have high face validity. AT-evoked
seizures in the rat are typical limbic-motor seizures, similar to those seen after low doses of
systemically-administered bicuculline, pentylenetetrazole, kainate, or after electrical kindling
[43,58]. These seizures are characterized by facial clonus (perhaps akin to lip smacking seen in
patients and monkeys), forelimb clonus (perhaps akin to arm posturing), and rearing with loss
of balance. The rearing and loss of balance seen in rats is strikingly different than the behaviors
observed in primate species.
Thus, by examining AT-evoked seizures across species, it has become clear that complex partial
seizures have species-specific behavioral manifestations but share the qualities of focal
automatisms and engage the same brain network.
9. Species specific nature of seizure spread: What is a generalized seizure?
In human patients, complex partial seizures that secondarily generalize have two characteristic
features: 1) involvement of the whole brain when the seizure generalizes and 2) tonic-clonic
manifestations when the seizure generalizes (as compared to automatisms prior to generali‐
zation).
In the monkey, AT-evoked seizures can secondarily generalize showing bilaterally asynchro‐
nous tonic-clonic and electrographic features. This pattern fits both the electrographic and
behavioral definitions used for secondary generalization in humans. In contrast, in the rat, AT-
evoked seizures do not show tonic-clonic (brainstem) manifestations, but rapidly show
bilateral synchronization of the limbic/cortical EEG and associated motor automatisms with
rearing and loss of balance. Thus, in the rat, it appears that the “path of least resistance” for
seizure propagation is transcallosal or commissural (hence bilaterally synchronized limbic
motor and electrographic manifestations) whereas in the primate it appears to be down the
neuraxis (hence the involvement of brainstem seizure networks).
Can, then, the limbic motor seizure with rearing and loss of balance in the rat (i.e., a Racine
Stage 5 seizure) be considered a secondarily generalized tonic-clonic seizure? Some have
suggested that because these seizures engage basal ganglia, they should be considered
generalized [59,60]. However, seizure activity in limbic-evoked motor seizures (i.e., Stage 5
amygdala kindled) engages basal ganglia substrates (substantia nigra pars reticulata) even
before other limbic structures (such as hippocampus) [61–63]. Moreover, because these
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seizures lack the prominent tonic-extensor phase (which requires brainstem engagement) seen
in secondarily generalized seizures in monkeys and humans, we suggest that the repeated
clonus and rearing/loss of balance that is characteristic of these seizures should not be
considered tonic-clonic. On this basis, we suggest that focal limbic seizures (e.g., seizures early
in kindling that do not engage the basal ganglia) are akin to simple partial seizures, seizures
that spread to the basal ganglia are akin to complex partial seizures (as they are still confined
to the forebrain), and only when hindbrain circuits are engaged should these seizures be
considered truly generalized.
10. Manipulating circuits with focal stimulation as a therapeutic
intervention
With the success of deep brain stimulation trials in epilepsy (e.g., stimulation of the anterior
nucleus of the thalamus), focal manipulation of circuitry for the control of epilepsy has become
a reality. However, identifying the best locations for targeting is a work-in-progress. Contin‐
ued circuit analysis in animals is essential, not only for identifying targets, but also for
examining newer approaches (e.g., optogenetics, chemical-genetics) that offer exciting levels
of specificity in cell-type and pathway-specific targeting [64-70].
One approach that remains underexplored clinically is enhancing the function of seizure-
suppressive network nodes that have been identified in animal models. One such node is the
substantia nigra pars reticulata [71–76]. Suppression of activity within this region is potently
anticonvulsant in a variety of seizure models, and across several species. This structure is
particularly compelling for further investigation because it is positioned at the interface of two
different seizure networks (i.e., the forebrain network, with heavy interconnections to limbic
structures, and the hindbrain network, projections to colliculus and brainstem targets). This
anatomical position may underlie the anticonvulsant effects that this region exerts across
seizure types: it decreases the duration of tonic hindlimb extension triggered by maximal
electroshock and it decreases seizures focally evoked from piriform cortex. As we continue to
refine our circuit maps, we open the door to therapeutic approaches such as suppressing
activity in seizure “distribution” nodes or activation of endogenous “surge suppressors“.
These possibilities that can only be realized through the use of appropriate animal models.
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